levodopa has been researched along with metanephrine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, RT; Spehlmann, R; Stahl, SM | 1 |
| Rinne, UK; Siirtola, T; Sonninen, V | 1 |
| Factor, SA; Schneider, AS | 1 |
| Davidson, DF; Grosset, D; Grosset, K | 1 |
| Breckenridge, A; Collier, A; Davidson, DF; Freel, EM; Ghosh, S; Perry, CG | 1 |
| Beuschlein, F; Brown, S; Eisenhofer, G; Fassnacht, M; Glöckner, S; Januszewicz, A; Lattke, P; Peitzsch, M; Pelzel, D; Prejbisz, A; Reichmann, H; Siegert, G; Stell, A | 1 |
| Bischoff, R; de Jong, WHA; Eijkelenkamp, K; Kema, IP; van der Ley, CP; van Faassen, M | 1 |
| Correia, MAS; Gallardo, E; Gonçalves, AM; Oliveira, AE; Oliveira, DM; Passarinha, LA; Pedro, AQ; Queiroz, JA; Romão, MJ; Santos, MFA | 1 |
1 trial(s) available for levodopa and metanephrine
| Article | Year |
|---|---|
Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Catecholamines; Creatinine; Dopamine; Female; Homovanillic Acid; Humans; Levodopa; Male; Metanephrine; Middle Aged; Norepinephrine; Normetanephrine; Parkinson Disease; Pheochromocytoma | 2007 |
7 other study(ies) available for levodopa and metanephrine
| Article | Year |
|---|---|
A pharmacologic study of the stiff-man syndrome. Correlation of clinical symptoms with urinary 3-methoxy-4-hydroxy-phenyl glycol excretion.
Topics: Diazepam; Glycine; Glycols; Homovanillic Acid; Humans; Levodopa; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Muscle Rigidity; Normetanephrine; Physostigmine; Spasm; Syndrome; Vanilmandelic Acid | 1975 |
Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations.
Topics: 3,4-Dihydroxyphenylacetic Acid; Benserazide; Biogenic Amines; Dopamine; Female; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Metanephrine; Middle Aged; Normetanephrine; Parkinson Disease; Tyramine; Vanilmandelic Acid | 1975 |
Peripheral catecholamine output in Parkinson's disease: effects of drug treatment.
Topics: Adrenal Medulla; Aged; Carbidopa; Catecholamines; Corpus Striatum; Epinephrine; Female; Humans; Levodopa; Male; Metanephrine; Middle Aged; Norepinephrine; Parkinson Disease; Vanilmandelic Acid | 1995 |
A phaeochromocytoma occurring in a patient with Parkinson's disease on L-dopa therapy: a diagnostic challenge.
Topics: Adrenal Gland Neoplasms; Antiparkinson Agents; Creatinine; Humans; Levodopa; Male; Metanephrine; Middle Aged; Normetanephrine; Parkinson Disease; Pheochromocytoma; Tomography, X-Ray Computed | 2012 |
Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Topics: Aged; Aged, 80 and over; Chromatography, Liquid; Dopamine; Epinephrine; Female; Humans; Levodopa; Male; Metanephrine; Middle Aged; Norepinephrine; Normetanephrine; Paraganglioma; Parkinson Disease; Pheochromocytoma; Tandem Mass Spectrometry | 2014 |
In Matrix Derivatization Combined with LC-MS/MS Results in Ultrasensitive Quantification of Plasma Free Metanephrines and Catecholamines.
Topics: Catecholamines; Chromatography, High Pressure Liquid; Dopamine; Humans; Levodopa; Limit of Detection; Metanephrine; Reference Values; Solid Phase Extraction; Tandem Mass Spectrometry | 2020 |
Thermofluor-Based Optimization Strategy for the Stabilization of Recombinant Human Soluble Catechol-
Topics: Carboxy-Lyases; Catechol O-Methyltransferase; Catechols; Cysteine; Dopamine; Estrogens; Glycerol; Humans; Ionic Liquids; Levodopa; Metanephrine; Parkinson Disease; Trehalose | 2022 |